Equal benefits to our residential courses, without the travel.View Courses
All our courses. 12 months access. One flat fee.More Information
Non-members can signup to keep up to date with RQA news and events.Add your details now
26th May 2021
The Committee adopted by consensus a positive opinion for a marketing authorisation application for Bonqat (pregabalin) from Orion Corporation, a new product for the alleviation of acute anxiety in cats.
The Committee adopted by consensus a positive opinion for a type II variation application for Simparica Trio concerning quality-related changes. The Committee also adopted by consensus a type IB variation grouped application (subject to a worksharing procedure) for Vectra 3D and Vectra Felis concerning quality-related changes.